Research map: Characteristics and risk factors of acquired drug resistance among people living with HIV: A retrospective study in Guangzhou, China (2018–2023)

Back to the article

Papers in this map

  1. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study · John Gregson · 2016 · 279 citations · Cited by this paper
  2. Characteristics and risk factors of acquired drug resistance among people living with HIV: A retrospective study in Guangzhou, China (2018–2023): Erratum · Shiyun Lv · 2025 · Cites this paper
  3. Critical updates in the 2024 influenza clinical practice guidelines of the World Health Organization · 2025 · Related
  4. Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001–2017) · Lulu Zuo · 2020 · 108 citations · Cited by this paper
  5. Prevalence and transmission of pretreatment drug resistance and acquired drug resistance among people living with HIV-1 in Chongqing, China, 2014–2024 · Wenwan Gao · 2026 · Cites this paper
  6. Viral capsid–VCP interactions govern flavivirus vector specificity · 2026 · Related
  7. Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection/acquired immunodeficiency syndrome (2024 edition) · If the screening test result is non-reactive · 2024 · 94 citations · Cited by this paper
  8. Global threats and regional trends: Navigating the complex landscape of human orthohantavirus infections · 2025 · Related
  9. AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study · Viviane Dias Lima · 2015 · 67 citations · Cited by this paper
  10. Caspofungin pre-emptive therapy failed to prevent susceptible Candida auris breakthrough infection or colonization: An in-depth clinical survey of four cases · 2025 · Related
  11. Drug resistance mutations in HIV: new bioinformatics approaches and challenges · Luc Blassel · 2021 · 58 citations · Cited by this paper
  12. Functional cure of infants with HBeAg-positive chronic hepatitis B receiving antiviral treatment: Case series · 2025 · Related
  13. Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996–2016 · Genevieve L. Y. Rocheleau · 2017 · 44 citations · Cited by this paper
  14. Clinical practice guidelines for the treatment and prophylaxis of influenza in China (2025 edition) · 2025 · Related
  15. An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China · Fengdi Zhang · 2017 · 37 citations · Cited by this paper
  16. Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection/acquired immunodeficiency syndrome (2024 edition) · 2024 · Related
  17. HIV-1 drug-resistant mutations and related risk factors among HIV-1-positive individuals experiencing treatment failure in Hebei Province, China · Xinli Lu · 2017 · 33 citations · Cited by this paper
  18. The current role, challenges, and future prospects of infectious disease physicians in the comprehensive management of hepatocellular carcinoma: A cross-sectional survey · 2025 · Related
  19. Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in Uganda · Jonah Omooja · 2019 · 26 citations · Cited by this paper
  20. Temporal trends and clinical outcomes of antiretroviral therapy initiation and regimens in treatment-naive people with HIV: A real-world study at a tertiary specialist hospital in Beijing, China · 2025 · Related
  21. Prevalence and trends in transmitted and acquired antiretroviral drug resistance, Washington, DC, 1999–2014 · Annette M. Aldous · 2017 · 25 citations · Cited by this paper
  22. HHV-6 reactivations in immunocompetent patients with psychiatric disorders: visual hallucinations or possible interactions? · 2025 · Related
  23. Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China · Xiaobai Zou · 2020 · 19 citations · Cited by this paper
  24. HIV-1 Drug Resistance and Genetic Transmission Networks Among MSM Failing Antiretroviral Therapy in South China 2014–2019 · Yun Lan · 2021 · 19 citations · Cited by this paper
  25. Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003–2012 decade in Italy · Marco Franzetti · 2014 · 18 citations · Cited by this paper
  26. Trends and predictors of HIV-1 acquired drug resistance in Minas Gerais, Brazil: 2002–2012 · Helena Duani · 2016 · 16 citations · Cited by this paper
  27. Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients · Irène A. Abela · 2019 · 16 citations · Cited by this paper
  28. Accumulation of HIV-1 Drug Resistance Mutations After First-Line Immunological Failure to Evaluate the Options of Recycling NRTI Drugs in Second-Line Treatment: A Study from South India · Sathasivam Sivamalar · 2016 · 14 citations · Cited by this paper
  29. The crosstalk between antiretrovirals pharmacology and HIV drug resistance · Andrea Giacomelli · 2020 · 11 citations · Cited by this paper
  30. Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China · Xianwu Pang · 2024 · 11 citations · Cited by this paper
  31. HIV‐1 Drug Resistance, Distribution of Subtypes, and Drug Resistance‐Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014‐2016 · Jiayi Chen · 2020 · 10 citations · Cited by this paper
  32. HIV drug resistance among patients experiencing antiretroviral therapy failure in Russia, 2019–2021 · Mariya V. Sivay · 2023 · 8 citations · Cited by this paper
  33. Marked decrease in acquired resistance to antiretrovirals in latest years in Italy · Alessia Lai · 2020 · 5 citations · Cited by this paper
  34. De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study · Piter Oosterhof · 2024 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)